Medizone International (OTCMKTS:MZEI) and AmerisourceBergen (NYSE:ABC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings.
Insider & Institutional Ownership
0.2% of Medizone International shares are owned by institutional investors. Comparatively, 66.2% of AmerisourceBergen shares are owned by institutional investors. 4.1% of Medizone International shares are owned by insiders. Comparatively, 27.3% of AmerisourceBergen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
AmerisourceBergen pays an annual dividend of $1.52 per share and has a dividend yield of 1.7%. Medizone International does not pay a dividend. AmerisourceBergen pays out 25.9% of its earnings in the form of a dividend. AmerisourceBergen has raised its dividend for 13 consecutive years.
Volatility & Risk
Medizone International has a beta of 3.68, meaning that its share price is 268% more volatile than the S&P 500. Comparatively, AmerisourceBergen has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.
Valuation and Earnings
This table compares Medizone International and AmerisourceBergen’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Medizone International||$230,000.00||7.76||-$2.01 million||N/A||N/A|
|AmerisourceBergen||$153.14 billion||0.12||$364.48 million||$5.88||14.90|
AmerisourceBergen has higher revenue and earnings than Medizone International.
This table compares Medizone International and AmerisourceBergen’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and target prices for Medizone International and AmerisourceBergen, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
AmerisourceBergen has a consensus target price of $101.71, suggesting a potential upside of 16.10%. Given AmerisourceBergen’s higher probable upside, analysts plainly believe AmerisourceBergen is more favorable than Medizone International.
AmerisourceBergen beats Medizone International on 11 of the 14 factors compared between the two stocks.
Medizone International Company Profile
Medizone International, Inc. develops, manufactures, and sells disinfection systems in the United States and internationally. It offers AsepticSure system, a disinfection system that is used in medical facilities, such as hospitals, clinics, physician's offices, outpatient surgical centers, and long-term care facilities; food industry; bio-safety labs; athletic facilities, such as gyms and locker rooms, as well as sports equipment; and mortuaries, bio-defense and response to pandemics, building remediation, tissue labs, sporting venues, and hotels, as well as clean rooms to disinfect hard and non-porous surfaces. The company was founded in 1986 and is based in Kalamazoo, Michigan.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Receive News & Ratings for Medizone International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medizone International and related companies with MarketBeat.com's FREE daily email newsletter.